Then separately, Musk announced he had sued OpenAI, saying that that company failed to remain true to the mission of benefiting humanity, and is dangerously aiming to maximize short term profits. [Is anyone surprised by either of these stories?]
Here's the bit about the 483s, via an exclusive at Reuters:
. . .The FDA has not issued its designation indicating the severity of problems found in the inspection, according to the agency's database. While the problems identified are serious, they do not appear to be significant enough to justify the FDA's worst inspection designation, which would prompt action, the experts said.
Carly Pflaum, an FDA spokesperson, said Neuralink "provided sufficient information to support the approval" of its human trial application. The agency routinely conducts such inspections, Pflaum said, after human trial approval and before commercial approval to "assure data integrity and reliability" and compliance with other FDA regulations.
"The FDA will continue to monitor the safety of those enrolled in the study for Neuralink's implant device through required, regular reports," Pflaum said. . . .
Of the two, it seems to me that Open AI poses the larger long term threat. I hate to seem a Luddite here, but I think we have no idea what will come of that initiative, if left solely in the hands of young MBAs looking to "monetize" it. Onward, nonetheless. . . smile.
नमस्ते
2 comments:
"[they] were so preoccupied with whether or not they could, that they didn't stop to think if they should."
That’s precisely right, anon.!
And twice overnight I thought of all the luminous yet clear ways… it might have ended better.
Namaste!
Post a Comment